Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-06-06

Clinical Trial Update: IGF1 Generation Test [Phase 4]

View source ↗

Summary

Pfizer completed a Phase 4 trial evaluating an IGF-1 generation test for growth hormone deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Pfizer | Conditions: Growth Hormone Deficiency | Phase 4 | Status: COMPLETED